BTG3 and prostate carcinoma: Btg3-deficient (Btg3–/–) mice display a higher incidence of lung tumors, and the downregulation of BTG3 has been observed in renal, breast, and prostate cancers [18–20], suggesting that BTG3 may play a role in suppressing tumorigenesis.